Sage Journals: Discover world-class research

Abstract

Antiphospholipid antibodies (APAs) are associated with venous thromboembolism in patients with systemic lupus erythematosus (SLE). In patients without SLE, but with deep vein thrombosis (DVT) this association is established only for patients with lupus anticoagulant (LA). In a case-controlled study APAs were determined in 171 consecutive outpatients who underwent phlebography at the first episode of clinically suspected DVT of lower limbs. Phlebography confirmed the presence of DVT in 54 (32%) patients and excluded it in 117. Antiphospholipid antibodies (exluding LA) were detected in 5 (9.2%) of the 54 patients with DVT and in 7 (5.9%) of the 117 subjects without DVT, The prevalence of APAs tended to be higher in patients with DVT than in patients without DVT, but the difference was not statistically significant (p = 0.3%). Antiphospholipid antibodies in the absence of LA are not associated with DVT in symptomatic patients. Therefore future studies should be performed before changing our clinical approach in APA-A positive but LA-negative patients. Key Words: Antiphospholipid antibodies-Deep vein thrombosis.

Get full access to this article

View all access options for this article.

References

Triplett DA Ahtiphospholipid-protein antibodies: Laboratory detection and clinical relevance . Thromb Res 1995;78:1-3 1.

Feinstein DI Lupus anticoagulant, anticardiolipin antibodies, fetal loss, and systemic lupus erythematosus. Blood 1992 80:859-62.

Bick RL , Baker WF Anticardiolipin antibodies and thrombosis. Haem Onc Clin N Am 1992;6:1287.

Long AA , Ginsberg J. Brill-Edwards P. , et al, The relationship of antiphospholipid antibodies to thromboembolic disease in SLE: A cross-sectional study. Thromb Haemost 1991;66:520-4.

Kapiotis S. , Speiser W. , Pabinger-Fasching I. , Kyrle PA , Lechner K. Anticardiolipin antibodies in patients with venous thrombosis. Haemostasis 1991;21:19.

Palareti G. , Legnani C. , Ludovici S. , Boggian O. , Coccheri S. Prevalence of high levels of antiphospholipid antibodies in otherwise unexplained juvenile venous thromboembolism. Thromb Haemost 1991;65:452.

Ginsberg JS , Wells PS , Brill-Edwards P. , Moffatt K. , Johnston M. , Steven P. , Hirsh J. Antiphospholipid antibodies and venous thromboembolism. Blood 1995;86:3685-91.

Lensing Awa , Buller HR , Prandoni P. , et al. Contrast venography, the gold standard for the diagnosis of deep-vein thrombosis: Improvement in observer agreement. Thromb Haemost 1992;67: 8-12.

Girolami A. , Simioni P. , Marchiori A. , Millar DS , Kakkar VV , Cooper DN A novel dysfunctional protein C (Protein C Padua 2) associated with a thrombothic tendency: Substitution of Cys for Arg-1 results in a strongly reduced affinity for binding of Ca++. Br J Haematol 1993;85:521.

10.

Girolami A. , Marafioti F. , Rubertelli M. , Vicarioto MA , Capellato G. , Mazzuccato M. Antithroinhin III Trento. A "new" congenital antithrombin III abnormality with a peculiar crossed-immunoelettroforetic pattern in the absence of heparin. Acta Haematol 1984;72:71-9.

11.

Simioni P. , de ronde H. , Prandoni P. , Saladini M. , Bertina RM , Girolami A. Ischemic stroke in young patients with activated protein C resistance: A report of three cases belonging to three different kindreds. Stroke 1995;26:885-90.

12.

Zanon E. , Saracino MA , Simioni P. , Cogo A. Fadin A, Gavasso Girolami A. Prevalence of antiphospholipid antibodies and lupus anticoagulant in juvenile patients with objectively documented deep-vein thrombosis. Clin Appl Thromb/Hemost 1996 ;2:69-73.

13.

Gilman-Sachs A. , Lubinski J. , Beer AE , Brend S. , Beaman KD Patterns of anti-phospholipid antibody specificities . J Clin Lab Immunol 1991;35:83-8.

14.

McNeil HP , Simpson RJ. Chesterman CN , Krilis SA Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: B2-glicoprotein I (apolipoprotein H). Proct Natl Acad Sci 1990;87:4120-4.

15.

Love PE , Santoro SA , Antiphospholipid antibodies, anticardiolipin and the lupus anticoagulant in systemic lupus erythematous (SLE) and in non-SLE disorders. Ann Intem Med 1990;112:682-98.

16.

Bongard O. , Reber G. , Bounameaux H. , de Moerloose P. Anticardiolipin antibodies in acute venous thromboembolism. Thromb Haemost 1992:67:724.

17.

Simioni P. , Zanon E. , Prandoni P. , Saracino MA , Cogo A. , Sardella C. , Girolami A. Lupus anticoagulant and antiphospholipid antibodies in outpatients with clinically suspected DVT. Lupus 1994; 3:361.

18.

Reber G. , Arvieux J. , Comby E. , de Moerloose P. , Sanmarco M. , Potron G. Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies. Thromb Haemost 1995; 73:442-52.

19.

Vila P. , Hernandez MC , Lopez-Fernandez MF , Batle J. Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects. Thromb Haemostas 1994;72:209-13.

20.

Simioni P. , Prandoni P. , Zanon E. , et al. Deep vein thrombosis and lupus anticoagulant: A case control study. Thromb Haemost 1996; 76:187-9.

21.

Rosove MH , Petronella MC , Brewer RN Antiphospholipid thrombosis: Clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992; 117:303-8.

22.

Khamashta MA , Cuadrado MJ , Mujic F. , Taub NA , Hunt BJ , Hughes Grv. The management of thrombosis in the antiphospholipid antibody syndrome. N Engl J Med 1995,332:993-7.

Antiphospholipid Antibodies Do Not Seem to Be Associated With Deep Vein Thrombosis: A Case Control Study

Abstract

Get full access to this article

References